Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 1,295,299 | 1,230,626 | 1,058,385 | 993,328 | 724,221 |
| Cost of Goods | 796,478 | 752,435 | 651,778 | 603,624 | 435,499 |
| Gross Profit | 498,821 | 478,191 | 406,607 | 389,704 | 288,722 |
| Operating Expenses | 951,138 | 251,467 | 219,212 | 205,634 | 131,235 |
| Operating Income | -451,839 | 227,159 | 188,173 | 184,694 | 157,986 |
| Interest Expense | 22,335 | 24,453 | 19,426 | 24,324 | 11,718 |
| Other Income | 2,728 | 8,235 | 7,817 | 3,518 | 4,199 |
| Pre-tax Income | -471,446 | 210,941 | 176,564 | 163,888 | 150,467 |
| Income Tax | 57,029 | 56,677 | 49,738 | 16,261 | 60,159 |
| Net Income Continuous | -528,475 | 154,264 | 125,221 | 145,789 | 88,731 |
| Net Income Discontinuous | 3,283 | -3,146 | -181,004 | -3,790 | 1,061 |
| Minority Interests | -687 | 470 | N/A | N/A | N/A |
| Net Income | $-524,505 | $150,648 | $-55,783 | $141,999 | $89,792 |
| EPS Basic Total Ops | -7.80 | 2.25 | -0.81 | 2.04 | 1.81 |
| EPS Basic Continuous Ops | -7.85 | 2.30 | 1.82 | 2.09 | 1.79 |
| EPS Basic Discontinuous Ops | 0.05 | -0.05 | -2.63 | -0.05 | 0.02 |
| EPS Diluted Total Ops | -7.80 | 2.19 | -0.80 | 1.96 | 1.68 |
| EPS Diluted Continuous Ops | -7.85 | 2.24 | 1.79 | 2.02 | 1.65 |
| EPS Diluted Discontinuous Ops | 0.05 | -0.05 | -2.59 | -0.05 | 0.02 |
| EBITDA(a) | $348,476 | $313,570 | $270,759 | $274,811 | $201,916 |